• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阳离子铁蛋白作为磁共振成像探针检测非酒精性脂肪性肝炎大鼠模型的微观结构变化。

Cationized ferritin as a magnetic resonance imaging probe to detect microstructural changes in a rat model of non-alcoholic steatohepatitis.

作者信息

Beeman Scott C, Mandarino Lawrence J, Georges Joseph F, Bennett Kevin M

机构信息

Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee.

出版信息

Magn Reson Med. 2013 Dec;70(6):1728-38. doi: 10.1002/mrm.24619.

DOI:10.1002/mrm.24619
PMID:23390010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4232496/
Abstract

PURPOSE

The goal of this work was to detect disease-related microstructural changes to the liver using magnetic resonance imaging. Chronic liver disease can cause microstructural changes in the liver that reduce plasma access to the perisinusoidal space--the site of exchange between the blood plasma and the hepatic parenchyma. The reduced plasma access to the perisinusoidal space inhibits hepatic function and contributes to the ∼30,000 chronic liver disease-related deaths per year.

METHODS

The extracellular matrix-specific cationized ferritin magnetic resonance imaging probe was injected intravenously into healthy rats and a rat model of the chronic liver disease non-alcoholic steatohepatitis. Rats were subsequently imaged with T2*-weighted magnetic resonance imaging.

RESULTS

This work demonstrates that the binding of cationized ferritin to the perisinusoidal extracellular matrix is reduced by 55% in a rat model of non-alcoholic steatohepatitis compared to healthy controls. This reduced binding is detectable in vivo with magnetic resonance imaging. Immunofluorescence and electron microscopy indicated that the reduced binding is due to inhibited macromolecular access to the perisinusoidal space caused by non-alcoholic steatohepatitis-related microstructural changes.

CONCLUSIONS

The reduced accumulation of intravenously injected cationized ferritin may report on changes in macromolecular access to the liver parenchyma in chronic liver disease.

摘要

目的

本研究旨在利用磁共振成像检测肝脏疾病相关的微观结构变化。慢性肝病可导致肝脏微观结构改变,减少血浆进入肝血窦周隙——血浆与肝实质进行交换的部位。血浆进入肝血窦周隙减少会抑制肝功能,导致每年约30000例与慢性肝病相关的死亡。

方法

将细胞外基质特异性阳离子铁蛋白磁共振成像探针静脉注射到健康大鼠和慢性肝病非酒精性脂肪性肝炎大鼠模型体内。随后用T2*加权磁共振成像对大鼠进行成像。

结果

本研究表明,与健康对照组相比,在非酒精性脂肪性肝炎大鼠模型中,阳离子铁蛋白与肝血窦周隙细胞外基质的结合减少了55%。这种结合减少可通过磁共振成像在体内检测到。免疫荧光和电子显微镜检查表明,结合减少是由于非酒精性脂肪性肝炎相关的微观结构变化导致大分子进入肝血窦周隙受到抑制。

结论

静脉注射阳离子铁蛋白的蓄积减少可能反映了慢性肝病中大分子进入肝实质的变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cd/4232496/79800d258017/nihms640550f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cd/4232496/c0682791b0da/nihms640550f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cd/4232496/a939861ea212/nihms640550f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cd/4232496/e17e1079d55b/nihms640550f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cd/4232496/da58edca7219/nihms640550f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cd/4232496/101c3225a5da/nihms640550f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cd/4232496/420e1579df7b/nihms640550f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cd/4232496/61d25730ed2a/nihms640550f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cd/4232496/ef395e08a7a7/nihms640550f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cd/4232496/79800d258017/nihms640550f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cd/4232496/c0682791b0da/nihms640550f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cd/4232496/a939861ea212/nihms640550f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cd/4232496/e17e1079d55b/nihms640550f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cd/4232496/da58edca7219/nihms640550f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cd/4232496/101c3225a5da/nihms640550f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cd/4232496/420e1579df7b/nihms640550f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cd/4232496/61d25730ed2a/nihms640550f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cd/4232496/ef395e08a7a7/nihms640550f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cd/4232496/79800d258017/nihms640550f9.jpg

相似文献

1
Cationized ferritin as a magnetic resonance imaging probe to detect microstructural changes in a rat model of non-alcoholic steatohepatitis.阳离子铁蛋白作为磁共振成像探针检测非酒精性脂肪性肝炎大鼠模型的微观结构变化。
Magn Reson Med. 2013 Dec;70(6):1728-38. doi: 10.1002/mrm.24619.
2
Toxicity, biodistribution, and ex vivo MRI detection of intravenously injected cationized ferritin.静脉注射的阳离子化铁蛋白的毒性、生物分布和体外 MRI 检测。
Magn Reson Med. 2013 Mar 1;69(3):853-61. doi: 10.1002/mrm.24301. Epub 2012 May 8.
3
Validation of water-fat MRI and proton MRS in assessment of hepatic fat and the heterogeneous distribution of hepatic fat and iron in subjects with non-alcoholic fatty liver disease.水脂 MRI 和质子 MRS 对非酒精性脂肪性肝病患者肝脂肪和肝脂肪及铁异质性分布评估的验证。
Eur J Radiol. 2018 Oct;107:7-13. doi: 10.1016/j.ejrad.2018.08.008. Epub 2018 Aug 11.
4
Unenhanced fat fraction ratios obtained by MR and enhanced T2* values with liver-specific MR contrast agents for diagnosis of non-alcoholic steatohepatitis in rats.通过磁共振成像(MR)获得的未增强脂肪分数比值以及使用肝脏特异性MR造影剂的增强T2*值用于大鼠非酒精性脂肪性肝炎的诊断。
Acta Radiol. 2011 Jul 1;52(6):658-64. doi: 10.1258/ar.2011.100360. Epub 2011 Apr 6.
5
Evaluation of hepatic function using dynamic contrast-enhanced magnetic resonance imaging in melanocortin 4 receptor-deficient mice as a model of nonalcoholic steatohepatitis.使用动态对比增强磁共振成像评估黑素皮质素4受体缺陷小鼠作为非酒精性脂肪性肝炎模型的肝功能。
Magn Reson Imaging. 2019 Apr;57:210-217. doi: 10.1016/j.mri.2018.11.013. Epub 2018 Nov 19.
6
Gd-EOB-DTPA-enhanced-MR imaging in the inflammation stage of nonalcoholic steatohepatitis (NASH) in mice.钆塞酸二钠增强磁共振成像在小鼠非酒精性脂肪性肝炎(NASH)炎症期的应用
Magn Reson Imaging. 2016 Jul;34(6):724-729. doi: 10.1016/j.mri.2016.03.009. Epub 2016 Mar 12.
7
Assessment of Nonalcoholic Fatty Liver Disease in Rats Using Quantitative Dynamic Contrast-Enhanced MRI.使用定量动态对比增强磁共振成像评估大鼠非酒精性脂肪性肝病
J Magn Reson Imaging. 2017 May;45(5):1485-1493. doi: 10.1002/jmri.25455. Epub 2016 Sep 8.
8
Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib.非酒精性脂肪性肝炎患者的 MRE、MRI-PDFF 与肝组织学的纵向相关性:selonsertib 二期临床试验数据分析。
J Hepatol. 2019 Jan;70(1):133-141. doi: 10.1016/j.jhep.2018.09.024. Epub 2018 Oct 4.
9
Gd-EOB-DTPA-enhanced T1ρ imaging vs diffusion metrics for assessment liver inflammation and early stage fibrosis of nonalcoholic steatohepatitis in rabbits.钆塞酸二钠增强T1ρ成像与扩散指标用于评估兔非酒精性脂肪性肝炎的肝脏炎症和早期纤维化
Magn Reson Imaging. 2018 May;48:34-41. doi: 10.1016/j.mri.2017.12.017. Epub 2017 Dec 24.
10
Noninvasive Differentiation between Hepatic Steatosis and Steatohepatitis with MR Imaging Enhanced with USPIOs in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study.磁共振成像联合超顺磁性氧化铁增强对非酒精性脂肪性肝病患者肝脂肪变与脂肪性肝炎的无创鉴别:一项概念验证研究。
Radiology. 2016 Mar;278(3):782-91. doi: 10.1148/radiol.2015150952. Epub 2015 Sep 7.

引用本文的文献

1
Development and Use of Human Recombinant Cu-rHCF as a Kidney Glomerulus-Targeted Contrast Agent for Positron Emission Tomography.人重组 Cu-rHCF 的发展和应用作为正电子发射断层扫描的肾小球靶向对比剂。
ACS Appl Bio Mater. 2024 Oct 21;7(10):6392-6397. doi: 10.1021/acsabm.4c01027. Epub 2024 Sep 6.
2
Biogenic Imaging Contrast Agents.生物成像对比剂。
Adv Sci (Weinh). 2023 Sep;10(25):e2207090. doi: 10.1002/advs.202207090. Epub 2023 Jul 3.
3
Mapping nephron mass in vivo using positron emission tomography.利用正电子发射断层扫描技术对活体肾单位进行成像。
Am J Physiol Renal Physiol. 2021 Feb 1;320(2):F183-F192. doi: 10.1152/ajprenal.00418.2020. Epub 2020 Dec 7.
4
In vivo measurements of kidney glomerular number and size in healthy and Os mice using MRI.利用 MRI 对健康和 Os 小鼠的肾脏肾小球数量和大小进行体内测量。
Am J Physiol Renal Physiol. 2019 Oct 1;317(4):F865-F873. doi: 10.1152/ajprenal.00078.2019. Epub 2019 Jul 24.
5
The Impact of Kidney Development on the Life Course: A Consensus Document for Action.肾脏发育对生命历程的影响:行动共识文件
Nephron. 2017;136(1):3-49. doi: 10.1159/000457967. Epub 2017 Mar 21.
6
MRI tools for assessment of microstructure and nephron function of the kidney.用于评估肾脏微观结构和肾单位功能的MRI工具。
Am J Physiol Renal Physiol. 2016 Dec 1;311(6):F1109-F1124. doi: 10.1152/ajprenal.00134.2016. Epub 2016 Sep 14.
7
Biocompatibility of ferritin-based nanoparticles as targeted MRI contrast agents.基于铁蛋白的纳米颗粒作为靶向磁共振成像造影剂的生物相容性。
Nanomedicine. 2016 Aug;12(6):1735-45. doi: 10.1016/j.nano.2016.03.007. Epub 2016 Apr 9.
8
Phenotyping by magnetic resonance imaging nondestructively measures glomerular number and volume distribution in mice with and without nephron reduction.通过磁共振成像进行表型分析可无损测量有或没有肾单位减少的小鼠的肾小球数量和体积分布。
Kidney Int. 2016 Feb;89(2):498-505. doi: 10.1038/ki.2015.316.
9
MRI-based glomerular morphology and pathology in whole human kidneys.基于 MRI 的全肾肾小球形态学和病理学。
Am J Physiol Renal Physiol. 2014 Jun 1;306(11):F1381-90. doi: 10.1152/ajprenal.00092.2014. Epub 2014 Mar 19.

本文引用的文献

1
Toxicity, biodistribution, and ex vivo MRI detection of intravenously injected cationized ferritin.静脉注射的阳离子化铁蛋白的毒性、生物分布和体外 MRI 检测。
Magn Reson Med. 2013 Mar 1;69(3):853-61. doi: 10.1002/mrm.24301. Epub 2012 May 8.
2
Quantification of glomerular number and size distribution in normal rat kidneys using magnetic resonance imaging.利用磁共振成像技术定量测定正常大鼠肾脏的肾小球数量和大小分布。
Nephrol Dial Transplant. 2012 Jan;27(1):100-7. doi: 10.1093/ndt/gfr273. Epub 2011 Jun 3.
3
Measuring glomerular number and size in perfused kidneys using MRI.使用 MRI 测量灌注肾脏中的肾小球数量和大小。
Am J Physiol Renal Physiol. 2011 Jun;300(6):F1454-7. doi: 10.1152/ajprenal.00044.2011. Epub 2011 Mar 16.
4
Simplified synthesis and relaxometry of magnetoferritin for magnetic resonance imaging.磁小体的简化合成及其弛豫性能用于磁共振成像。
Magn Reson Med. 2010 Nov;64(5):1260-6. doi: 10.1002/mrm.22526.
5
Modified natural nanoparticles as contrast agents for medical imaging.改性天然纳米颗粒作为医学成像的对比剂。
Adv Drug Deliv Rev. 2010 Mar 8;62(3):329-38. doi: 10.1016/j.addr.2009.11.005. Epub 2009 Nov 6.
6
Nonalcoholic fatty liver disease.非酒精性脂肪性肝病
J Lipid Res. 2009 Apr;50 Suppl(Suppl):S412-6. doi: 10.1194/jlr.R800089-JLR200. Epub 2008 Dec 12.
7
A human ferritin iron oxide nano-composite magnetic resonance contrast agent.一种人铁蛋白氧化铁纳米复合磁共振造影剂。
Magn Reson Med. 2008 Nov;60(5):1073-81. doi: 10.1002/mrm.21761.
8
MRI of the basement membrane using charged nanoparticles as contrast agents.使用带电纳米颗粒作为造影剂对基底膜进行磁共振成像。
Magn Reson Med. 2008 Sep;60(3):564-74. doi: 10.1002/mrm.21684.
9
Hepatic microcirculation in fatty liver disease.脂肪性肝病中的肝微循环
Anat Rec (Hoboken). 2008 Jun;291(6):684-92. doi: 10.1002/ar.20715.
10
Controlled aggregation of ferritin to modulate MRI relaxivity.铁蛋白的可控聚集以调节磁共振成像弛豫率。
Biophys J. 2008 Jul;95(1):342-51. doi: 10.1529/biophysj.107.116145. Epub 2008 Mar 7.